Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_assertion type Assertion NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_head.
- NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_assertion description "[These results suggest that GSTM4 polymorphisms are biomarkers for the prediction of cisplatin response. ABCC4 polymorphisms, as well as GSTT1 copy number, may also help to predict cisplatin response, but further validation is required. These results represent a step toward the individualized chemotherapy of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_provenance.
- NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_assertion evidence source_evidence_literature NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_provenance.
- NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_assertion SIO_000772 20200426 NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_provenance.
- NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_assertion wasDerivedFrom gad-20130706 NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_provenance.
- NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_assertion wasGeneratedBy ECO_0000203 NP43032.RAzLj8yU_4nygfbegFMTiZM9jhP5ZhnnInWetjyhokBLI130_provenance.